Replies to post #179747 on Biotech Values

[jbog]

The WSJ had a interesting article looking at the cost of HCV long term.

http://blogs.wsj.com/pharmalot/2014/06/24/what-impact-will-hepatitis-c-drugs-have-on-medical-costs-look-here/?KEYWORDS=hepatitis

[Rocky3]

$MVIRB $JNJ $GILD $ABBV - so first big earnings is tomorrow AM from $JNJ - I am still at $1.2B +/- for WW sales of Olysio - have all the MVIRB that I want for the time being - will probably hold through its earnings in August unless the sales are much lower than I expect - TWT